Metastatic Pancreatic Carcinoma Recruiting Phase 1 Trials for Hydroxychloroquine (DB01611)

IndicationStatusPhase
DBCOND0031261 (Metastatic Pancreatic Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03825289Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic CancerTreatment